The Role Of Oxygen Therapy As Second-line Treatment For Patients With Obstructive Sleep Apnoea Who Are Intolerant Of Continuous Positive Airway Pressure Therapy, And Characterising Ventilatory Loop Gain As A Predictor Of The Success Of Therapy.
Funder
National Health and Medical Research Council
Funding Amount
$87,198.00
Summary
Obstructive sleep apnoea (OSA) is an increasingly common condition in Australia. Continuous positive airway pressure (CPAP) therapy is the _gold-standard� in OSA treatment, but a majority of sufferers are unable to tolerate this for the period required to treat their condition. We will be conducting a large Australian multi-centre, randomised, placebo controlled trial to investigate the utility of nocturnal oxygen therapy alone, in those people with OSA who are unable to tolerate CPAP.
Optimising The Management Of Patients With Atrial Fibrillation - The Standard Vs Atrial Fibrillation SpEcific ManagemenT StudY (SAFETY)
Funder
National Health and Medical Research Council
Funding Amount
$65,040.00
Summary
To optimise the management of patients with AF, we will conduct an intervention clinical trial, the goal of which is to develop and implement a care program that aims to improve the health of patients with AF. This will be done by comparing the usual care that patients would normally receive in hospital and in the community with a specialised and individualised health care program - the Standard vs Atrial Fibrillation spEcific managemenT studY (SAFETY).
The Identification And Treatment Of Cognitive And Social Deficits In Neurofibromatosis Type 1
Funder
National Health and Medical Research Council
Funding Amount
$99,073.00
Summary
Cognitive, learning and social difficulties are frequently reported in children with neurofibromatosis type 1 (NF1). There is an absence of research into the underlying causes of social problems in NF1 and only a handful of studies have reported on therapeutic possibilities. We will examine the relationship between theory of mind, ADHD, cognition and social functioning in NF1. We will also evaluate the efficacy of Ritalin as a treatment of cognition and social skills in NF1.